Documents

An ENCePP study - Impact of risk minimisation among users of rosiglitazone-containing products

Reflections of outgoing ENCePP Steering Group

Report from ENCePP WG2

Feedback from PML Workshop

Feedback from Rare Diseases Workshop

ENCePP Steering Group Elections

Meta-analysis and pooling of data

Highlights from informal PhVWP

EMA Geriatric Medicines Strategy

PROTECT-EU2P Training Platform